List of LDA Newsletters
GivingTuesday 11/30/21 is just around the corner. It is an International Day of Giving. LDA will continue our Annual Giving Campaign in conjunction with #GivingTuesday. This year LDA will focus on the four pillars of our mission: education, prevention, research, and patient support. Your donations will help LDA fulfill our mission. will help LDA fulfill […]
In a recently published review article,* authors provide a comprehensive summary of treatment options for pregnant patients with less common bacterial, fungal, and viral infections, including several tick-borne diseases (Lyme disease, ehrlichiosis, human granulocytic anaplasmosis, human monocytic ehrlichiosis, babesiosis, and Rocky Mountain spotted fever). This review provides guidance to clinicians based on the most recently published evidence-based research and expert recommendations.
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment.
The Lyme Disease Association Inc. and Columbia University Vagelos College of Physicians & Surgeons are jointly providing the 21st annual CME scientific conference, Lyme & Other Tick-Borne Diseases: Research for a Cure, virtually, on October 2, 2021. This conference is designed to meet the high standards for continuing medical education credits for medical & health professionals and researchers.
Take advantage of early bird discounts! Early Bird Rates End on August 15. All information can be found on the conference website link. Registration fees & dates: CME $275 Early Bird / $325 after Aug. 15th/ more “at door” & Non-CME $225 Early Bird / $260 after Aug. 15th/ more “at door.”
In a study with lead author, Dr. Brian Fallon, using Denmark’s National Patient Registry and Psychiatric Central Research Registry – including all persons living in Denmark from 1994-2016 – the risk of mental disorders and suicides among all diagnosed with Lyme borreliosis was assessed. Those individuals with Lyme borreliosis had higher rates of any mental and affective disorders, and suicide attempts or deaths by suicide compared with those without Lyme.
Elizabeth L. Maloney, MD, reviews the US trial evidence on EM rashes, problems of the IDSA recommendations considering that evidence, and provides evidence-based patient-centered strategies for managing patients with EM. “The EM rash is the hallmark finding of early disease,” along with other symptoms. “In light of the physical and financial costs, identifying and promoting highly effective therapeutic interventions for US patients with erythema migrans (EM) rashes that return them to their pre-infection health status should be a priority.”
Today, during May Lyme Disease Awareness Month, Congressman Christopher Smith (NJ-4-R) introduced a bill which could change the way our children with Lyme disease have been treated for decades. Co-sponsors are new Lyme Caucus Co-Chair, Rep. Henry Cuellar (TX-28-D), Lyme Caucus Member Rep. Bill Posey (FL-8-R), Rep. Josh Gottheimer (NJ-5-D), and Rep. Brian Fitzpatrick (PA-1-R). The bill, “Children Inflicted by Lyme Disabilities Act 2021,” or “CHILD Act 2021” will amend the Individuals with Disabilities Education Act (IDEA) by adding “including Lyme disease and other tick-borne diseases” in the Individuals with Disabilities Education Act (IDEA) after “other health impairments.”
We need your help immediately. We have a two-day window to act to help get Co-Sponsors on an important bill. Congressional Lyme Caucus Co-Chair, Christopher Smith, is introducing the “Children Inflicted by Lyme Disabilities Act 2021,” or “CHILD Act 2021,” this week into the US House of Representatives. The bill is “To amend the Individuals with Disabilities Education Act (IDEA) to recognize more clearly that Lyme disease can cause disabilities that affect the education of children and to enhance educational services and related services for children with Lyme disease and other tick-borne diseases and for other purposes.”
Joseph J. Burrascano Jr. MD is a physician who was an early innovator in the field of tick-borne diseases, having begun his clinical research in the mid-1980s in cooperation with several other key pioneers. In addition, he is well known for his educational presentations and for his monographs on diagnostic and treatment guidelines for Lyme and related tick-borne illnesses – a classic series that has been freely circulated around the world since 1989.
